Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 began with optimism about the domestic economy and attractive Small Cap valuations, but was impacted by volatility from Middle East geopolitical unrest and changing interest rate expectations. This unrest drove energy prices up and created cautious global markets. Energy, Basic Materials, and Industrials performed well, while software companies faced challenges due to AI disruption concerns. Market sensitivity to geopolitical events, energy prices, and inflation remains high. The Conestoga Small Cap Composite fell 5.01%, underperforming the Russell 2000 Growth’s -2.81% return. The decline was driven by negative stock selection and headwinds in Technology and Health Care, with sector allocation benefits insufficient to offset losses. In addition, please check the Strategy’s top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Conestoga Capital Advisors highlighted stocks like Azenta, Inc. (NASDAQ:AZTA). Azenta, Inc. (NASDAQ:AZTA) is a US-based life science company that focuses on biological and chemical compound sample exploration and management solutions. On April 27, 2026, Azenta, Inc. (NASDAQ:AZTA) closed at $25.15 per share. One-month return of Azenta, Inc. (NASDAQ:AZTA) was 19.03%, and its shares lost 5.49% over the past 52 weeks. Azenta, Inc. (NASDAQ:AZTA) has a market capitalization of $1.16 billion.
Conestoga Capital Advisors stated the following regarding Azenta, Inc. (NASDAQ:AZTA) in its Q1 2026 investor letter:
“Azenta, Inc. (NASDAQ:AZTA) provides life sciences solutions focused on sample management and multiomics services. Shares declined as results highlighted ongoing operational challenges and uneven execution. While revenue was broadly in line, profitability came under pressure, with gross margin declining 380 basis points due to weaker volumes and project-related costs. Management acknowledged the turnaround remains in progress, and investors appeared focused on the lack of near-term improvement and continued variability in performance.”
Azenta, Inc. (NASDAQ:AZTA) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 32 hedge fund portfolios held Azenta, Inc. (NASDAQ:AZTA) at the end of the fourth quarter, up from 26 in the previous quarter. In the first quarter of 2026, Azenta, Inc. (NASDAQ:AZTA) reported revenue of $149 million, up 1% on a reported basis but down 1% on an organic basis with a 2% headwind from foreign exchange. While we acknowledge the risk and potential of Azenta, Inc. (NASDAQ:AZTA) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Azenta, Inc. (NASDAQ:AZTA) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
